Access cutting-edge seizures treatment through this clinical trial at a research site in Little Rock. Study-provided care at no cost to qualified participants.
Access seizures specialists in Little Rock at no cost
This study follows strict safety protocols and ethical guidelines
All study-related seizures treatment provided free
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 administered as adjunctive treatment in primary generalized tonic-clonic seizures (PGTCS).
Sponsor: Xenon Pharmaceuticals Inc.
Check if you qualify for this seizures clinical trial in Little Rock, AR
If you're searching for seizures treatment options in Little Rock, AR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Little Rock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced seizures specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.